No Data
No Data
Three key points to pay attention to in the morning session - nvidia's earnings have passed, but individual stocks related to defense and currency etf etc are being selected.
In the trading session on the 21st, attention should be focused on the following three points: ■ The earnings reports for nvidia have passed, but there is individual stock picking related to defense and cryptocurrency. ■ No earnings reports were released. ■ Key materials for the morning session: Sumitomo Corporation, acquisition of agrochemicals in Vietnam, gaining a major distribution network, and pursuing aggressive strategies in a growth market. The Japanese stock market on the 21st is expected to begin with selling pressure, but there may gradually be signs of resilience in market developments. On the 20th, the usa market saw the dow jones industrial average increase by 139 points, and the nasdaq...
Sumitomo Corporation, Canadavia, etc. [List of stock information from newspapers]
*Sumitomo Corporation <8053> acquires agrochemicals in Vietnam, gains access to a major sales network, and launches an offensive in a growing market. (Nikkan Kogyo front page) -○*MinebeaMitsumi <6479> Group's ABLIC enters the field of composite power circuits, focusing on those for car cameras next spring. (Nikkan Kogyo front page) -○*Zenken <7371> provides support for accepting foreign care workers, collaborating with local governments. (Nikkan Kogyo page 4) -○*Yokohama Rubber <5101> and Tsukuba University visualize rubber internal structure clearly. (Nikkan Kogyo page 7) -○*Canadia <7004> Capacity 1
Saibu Gas Holdings: Confirmation letter
Saibu Gas Holdings: Semi-Annual Report - Term 132 (2024/04/01 - 2025/03/31)
Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.
Canon Inc-Spons ADR <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased by 0.8 points from the same period last year to 47.8%, due to cost reductions and favorable product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. [Positive evaluation] Takeda Pharmaceuticals Mid-Term <4502> | <7735> S
Saibu Gas Holdings: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (consolidated)
No Data
No Data